8-chloro-cyclic adenosine monophosphate and Milk-Alkali Syndrome

8-chloro-cyclic adenosine monophosphate has been researched along with Milk-Alkali Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harris, AL; Long, L; Mawer, EB; O'Byrne, KJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Whitehouse, RM	1
Dodds, M; Howie, AF; Langdon, SP; Leonard, RC; Miller, WR; Muir, M; Ritchie, AA; Stockman, PK	1
Braybrooke, JP; Dowsett, M; Ganesan, TS; Harris, AL; Long, L; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M	1

Trials

2 trial(s) available for 8-chloro-cyclic adenosine monophosphate and Milk-Alkali Syndrome

Article	Year
A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:12 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adolescent; Adult; Antineoplastic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Hypercalcemia; Neoplasms; Parathyroid Hormone; Vitamin D	1997
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:7 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adult; Aged; Antineoplastic Agents; Cytokines; Female; Hormones; Humans; Hypercalcemia; Kidney; Liver; Lymphocyte Subsets; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting	1999

Article

Year

A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors.

The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:12

Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adolescent; Adult; Antineoplastic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Hypercalcemia; Neoplasms; Parathyroid Hormone; Vitamin D

1997

Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:7

Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adult; Aged; Antineoplastic Agents; Cytokines; Female; Hormones; Humans; Hypercalcemia; Kidney; Liver; Lymphocyte Subsets; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting

1999

Other Studies

1 other study(ies) available for 8-chloro-cyclic adenosine monophosphate and Milk-Alkali Syndrome

Article	Year
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:3 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Prostatic Neoplasms; Transplantation, Heterologous; Weight Loss	1998

Article

Year

Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts.

European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:3

Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Prostatic Neoplasms; Transplantation, Heterologous; Weight Loss

1998